Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
signs and symptoms pathological conditions | D013568 |
Brand Name | Status | Last Update |
---|---|---|
ifex | New Drug Application | 2018-07-26 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
cystitis | EFO_1000025 | D003556 | N30 |
hemorrhage | MP_0001914 | D006470 | R58 |
Code | Description |
---|---|
J9209 | Injection, mesna, 200 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 6 | 10 | 2 | 1 | — | 15 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | 2 | 3 | 3 | 1 | — | 7 |
Medulloblastoma | D008527 | — | — | 1 | 2 | 1 | 1 | 1 | 6 |
Diffuse scleroderma | D045743 | EFO_0000404 | — | — | 1 | — | 1 | — | 2 |
Pleural effusion | D010996 | HP_0002202 | J90 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 13 | 29 | 2 | — | 3 | 42 |
Sarcoma | D012509 | — | — | 11 | 13 | 6 | — | 4 | 30 |
Leukemia | D007938 | — | C95 | 7 | 19 | 3 | — | 3 | 30 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 11 | 18 | 1 | — | 1 | 24 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 6 | 15 | 2 | — | — | 17 |
Hodgkin disease | D006689 | — | C81 | 6 | 10 | 1 | — | 3 | 15 |
Neuroblastoma | D009447 | EFO_0000621 | — | 6 | 5 | 1 | — | 1 | 13 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 2 | 7 | 1 | — | 1 | 10 |
Germ cell and embryonal neoplasms | D009373 | — | — | 2 | 4 | 1 | — | 2 | 8 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 7 | 1 | — | — | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 9 | 14 | — | — | 2 | 21 |
Melanoma | D008545 | — | — | 8 | 14 | — | — | 1 | 20 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | 15 | — | — | 3 | 19 |
Myeloid leukemia acute | D015470 | — | C92.0 | 8 | 12 | — | — | 1 | 18 |
Neoplasms | D009369 | — | C80 | 10 | 4 | — | — | 1 | 13 |
Hematologic neoplasms | D019337 | — | — | 4 | 10 | — | — | 1 | 11 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 8 | — | — | — | 8 |
Ewing sarcoma | D012512 | EFO_0000173 | — | 2 | 5 | — | — | 1 | 7 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | 6 | — | — | — | 6 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 6 | — | — | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 2 | — | — | — | — | 2 |
Wilms tumor | D009396 | EFO_0000212 | — | 2 | — | — | — | — | 2 |
Ganglioneuroblastoma | D018305 | — | — | 1 | — | — | — | — | 1 |
Vasculitis | D014657 | HP_0002633 | — | 1 | — | — | — | — | 1 |
Muscular diseases | D009135 | HP_0003198 | G72.9 | 1 | — | — | — | — | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | — | 1 |
Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | 1 | — | — | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | 1 | — | — | — | — | 1 |
Rhabdoid tumor | D018335 | — | — | 1 | — | — | — | — | 1 |
Clear cell sarcoma | D018227 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Vomiting | D014839 | HP_0002013 | R11.1 | — | — | — | — | 2 | 2 |
Nausea | D009325 | HP_0002018 | R11.0 | — | — | — | — | 1 | 1 |
Langerhans-cell histiocytosis | D006646 | — | C96.6 | — | — | — | — | 1 | 1 |
Wiskott-aldrich syndrome | D014923 | EFO_0003903 | D82.0 | — | — | — | — | 1 | 1 |
Severe combined immunodeficiency | D016511 | HP_0004430 | D81.0 | — | — | — | — | 1 | 1 |
Hemophagocytic lymphohistiocytosis | D051359 | — | D76.1 | — | — | — | — | 1 | 1 |
Chronic granulomatous disease | D006105 | EFO_0000338 | D71 | — | — | — | — | 1 | 1 |
Chediak-higashi syndrome | D002609 | Orphanet_167 | D72.0 | — | — | — | — | 1 | 1 |
Hyper-igm immunodeficiency syndrome | D053306 | Orphanet_101088 | D80.5 | — | — | — | — | 1 | 1 |
Primitive neuroectodermal tumors | D018242 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Mesna |
INN | mesna |
Description | Mesna, sold under the brand name Mesnex among others, is a medication used in those taking cyclophosphamide or ifosfamide to decrease the risk of bleeding from the bladder. It is used either by mouth or injection into a vein.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=S(=O)([O-])CCS.[Na+] |
PDB | — |
CAS-ID | 19767-45-4 |
RxCUI | — |
ChEMBL ID | CHEMBL975 |
ChEBI ID | — |
PubChem CID | 29769 |
DrugBank | — |
UNII ID | NR7O1405Q9 (ChemIDplus, GSRS) |